A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
Clinical trial NCT06376253 · TERMINATED
Trial details
- NCT number
- NCT06376253
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-08
- Primary completion
- 2025-07-10
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.